Transcription occurs in the nucleus, where RNA polymerase copies DNA into mRNA. The mRNA then exits the nucleus through the nuclear pore and enters the cytoplasm. In the cytoplasm, ribosomes use the mRNA as a template to assemble amino acids specified by the mRNA into a polypeptide chain through translation.
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...QIAGEN
Non-coding RNAs (ncRNAs), especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) have shown aberrant expression profiles in neurodegenerative disorders. This slideshow reviews the roles of lncRNAs and their mechanisms of action in the regulation of neurodegeneration. Learn more about novel solutions to isolate RNAs from blood and cerebral spinal fluid (CSF). A new qPCR-based lncRNA platform for lncRNA detection and profiling is also presented.
This document discusses long non-coding RNAs (lncRNAs). It begins by describing the discovery of lncRNAs in the 1980s-2000s through cDNA sequencing. It then states that lncRNAs are the largest class of transcripts in mouse and human genomes. The document discusses that lncRNAs were once thought to be useless but are now known to have regulatory functions. It provides details on the characteristics, locations in the genome, functions, mechanisms of action, roles in human disease, and implications in human carcinomas of lncRNAs.
RNAi and microRNA-mediated gene regulationBrianna Bibel
The document discusses RNA interference and microRNA, which are types of small non-coding RNAs that regulate gene expression through translational inhibition or degradation of target messenger RNAs. Small interfering RNAs and microRNAs are produced from precursor molecules through a biogenesis pathway involving the enzymes Dicer and the Microprocessor complex, and are then loaded onto an Argonaute protein within the RNA-induced silencing complex to target messenger RNAs with either perfect or partial complementarity, leading to repression of gene expression.
This document discusses a study investigating microRNAs (miRNAs) encoded by Cyprinid Herpesvirus-3 (CyHV-3). The researchers identified 6 high probability pre-miRNA candidates through deep sequencing of CyHV-3 infected cells and subsequent validation using DNA microarrays. The miRNAs showed characteristics consistent with viral miRNAs, including discrete enriched loci and miRNA-like alignment signatures. DNA array hybridization confirmed that the candidates identified through deep sequencing were genuinely abundant transcripts and not artifacts of sequencing bias. This study provides evidence that CyHV-3 encodes miRNAs that may play important roles during latent infection.
This document discusses RNA interference (RNAi), a biological mechanism that leads to post-transcriptional gene silencing triggered by double-stranded RNA molecules. It was discovered in 1998 by Fire and Mello, who received the Nobel Prize for this work. The mechanism involves double-stranded RNA being processed by the enzyme Dicer into small interfering RNAs that integrate into the RNA-induced silencing complex and guide mRNA degradation. RNAi can be induced by synthetic siRNAs or endogenous microRNAs and represents a powerful tool for studying gene function and developing therapies.
The human genome is pervasively transcribed, giving rise to an increasing number of long non-coding RNA genes. Most of these genes are novel or poorly characterized, and their relevance in human health and disease remains elusive. In our lab, we have developed various tools to study lncRNAs, amongst others to assess their role in cancer. As such, we are looking for novel biomarkers and therapeutic targets. I will describe various tools and ongoing research programs, including a comprehensive annotated catalog of human lncRNAs (LNCipedia), a targeted screen for focal lncRNA copy number alterations, a web tool for antisense oligonucleotide design, Zipper plot to visualize the transcriptional activity of lncRNAs in their genomic context, decodeRNA functional context mapping, and probe based lncRNA capture sequencing in body fluids.
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Two types of small ribonucleic acid (RNA) molecules – microRNA (miRNA) and small interfering RNA (siRNA) – are central to RNA interference.
This document discusses RNA interference (RNAi) and its mechanisms. It can be summarized as follows:
1. RNAi is a process where double-stranded RNA causes degradation of homologous mRNA sequences. It was discovered in 1998 and is found across many organisms.
2. The RNAi pathway involves conversion of dsRNA to siRNAs by the enzyme Dicer. siRNAs are incorporated into the RISC complex containing Argonaute proteins. RISC then cleaves and destroys homologous mRNA targets.
3. miRNAs are endogenous single-stranded RNAs that regulate gene expression at the translation level by preventing ribosome binding. They are processed from hairpin precursors by the enzymes Dro
The Central Roles of Non-coding RNAs in Neurodegenerative Disorders: Neurode...QIAGEN
Non-coding RNAs (ncRNAs), especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) have shown aberrant expression profiles in neurodegenerative disorders. This slideshow reviews the roles of lncRNAs and their mechanisms of action in the regulation of neurodegeneration. Learn more about novel solutions to isolate RNAs from blood and cerebral spinal fluid (CSF). A new qPCR-based lncRNA platform for lncRNA detection and profiling is also presented.
This document discusses long non-coding RNAs (lncRNAs). It begins by describing the discovery of lncRNAs in the 1980s-2000s through cDNA sequencing. It then states that lncRNAs are the largest class of transcripts in mouse and human genomes. The document discusses that lncRNAs were once thought to be useless but are now known to have regulatory functions. It provides details on the characteristics, locations in the genome, functions, mechanisms of action, roles in human disease, and implications in human carcinomas of lncRNAs.
RNAi and microRNA-mediated gene regulationBrianna Bibel
The document discusses RNA interference and microRNA, which are types of small non-coding RNAs that regulate gene expression through translational inhibition or degradation of target messenger RNAs. Small interfering RNAs and microRNAs are produced from precursor molecules through a biogenesis pathway involving the enzymes Dicer and the Microprocessor complex, and are then loaded onto an Argonaute protein within the RNA-induced silencing complex to target messenger RNAs with either perfect or partial complementarity, leading to repression of gene expression.
This document discusses a study investigating microRNAs (miRNAs) encoded by Cyprinid Herpesvirus-3 (CyHV-3). The researchers identified 6 high probability pre-miRNA candidates through deep sequencing of CyHV-3 infected cells and subsequent validation using DNA microarrays. The miRNAs showed characteristics consistent with viral miRNAs, including discrete enriched loci and miRNA-like alignment signatures. DNA array hybridization confirmed that the candidates identified through deep sequencing were genuinely abundant transcripts and not artifacts of sequencing bias. This study provides evidence that CyHV-3 encodes miRNAs that may play important roles during latent infection.
This document discusses RNA interference (RNAi), a biological mechanism that leads to post-transcriptional gene silencing triggered by double-stranded RNA molecules. It was discovered in 1998 by Fire and Mello, who received the Nobel Prize for this work. The mechanism involves double-stranded RNA being processed by the enzyme Dicer into small interfering RNAs that integrate into the RNA-induced silencing complex and guide mRNA degradation. RNAi can be induced by synthetic siRNAs or endogenous microRNAs and represents a powerful tool for studying gene function and developing therapies.
The human genome is pervasively transcribed, giving rise to an increasing number of long non-coding RNA genes. Most of these genes are novel or poorly characterized, and their relevance in human health and disease remains elusive. In our lab, we have developed various tools to study lncRNAs, amongst others to assess their role in cancer. As such, we are looking for novel biomarkers and therapeutic targets. I will describe various tools and ongoing research programs, including a comprehensive annotated catalog of human lncRNAs (LNCipedia), a targeted screen for focal lncRNA copy number alterations, a web tool for antisense oligonucleotide design, Zipper plot to visualize the transcriptional activity of lncRNAs in their genomic context, decodeRNA functional context mapping, and probe based lncRNA capture sequencing in body fluids.
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Two types of small ribonucleic acid (RNA) molecules – microRNA (miRNA) and small interfering RNA (siRNA) – are central to RNA interference.
This document discusses RNA interference (RNAi) and its mechanisms. It can be summarized as follows:
1. RNAi is a process where double-stranded RNA causes degradation of homologous mRNA sequences. It was discovered in 1998 and is found across many organisms.
2. The RNAi pathway involves conversion of dsRNA to siRNAs by the enzyme Dicer. siRNAs are incorporated into the RISC complex containing Argonaute proteins. RISC then cleaves and destroys homologous mRNA targets.
3. miRNAs are endogenous single-stranded RNAs that regulate gene expression at the translation level by preventing ribosome binding. They are processed from hairpin precursors by the enzymes Dro
RNA interference (RNAi) is a mechanism that inhibits gene expression through degradation of mRNA. It was discovered in 1998 when researchers found that injecting double-stranded RNA into worms caused specific gene silencing. The mechanism involves dicer enzymes cutting double-stranded RNA into small interfering RNAs (siRNAs) which are incorporated into the RNA-induced silencing complex (RISC) and guide it to degrade complementary mRNA targets. siRNAs can be designed to target specific genes and various delivery methods exist to introduce siRNAs into cells and organisms. RNAi has applications in research, therapeutics, and agriculture by allowing targeted gene silencing.
Gene silencing and its application in crop improvementVINOD BARPA
Gene silencing is describing as epigenetic processes of gene regulation. Gene silencing is a technique used to turn down or switch off the activity of genes by a mechanism other than genetic modification. That is, a gene which would be expressed (turned on) under normal circumstances is switched off by machinery in the cell.
Gene silencing (GS) is defined as a molecular process involved in the down regulation of specific genes, the mechanisms of Gene silencing that suppress gene activity in plants has extended that control of gene expression. Currently, there are several routes of GS identified in plants, such as: transcriptional gene silencing and post transcriptional (PTGS or RNAi) gene silencing (Fire et al. 1998), microRNA silencing and virus induced gene silencing. All these pathways play an important role at the cellular level, affecting gene regulation and protection against viruses and transposons. The post-transcriptional gene silencing involves breakdown of the mRNA itself by various techniques like Ribozymes, antisense RNA, DNAzymes and RNA interference (RNAi). Among all these techniques RNA interference has emerged as most potent tool to effect targeted gene silencing and is being used to determine the function of genes which are expressed in a constitutive or cell-fate dependent manner.
RNAi interuption mechanism and applicationSumeena Karki
RNA interference is a natural mechanism that inhibits gene expression. It was first discovered accidentally in 1990 when researchers trying to increase pigmentation in petunias found that introduced homologous RNA led to less pigmentation. Further work found similar mechanisms in plants and fungi termed cosuppression and quelling. Craig Mello and Andrew Fire's 1998 paper demonstrating gene silencing in C. elegans using double stranded RNA led to the coining of the term RNAi. The mechanism involves Dicer and Drosha enzymes processing trigger RNA into siRNAs which are loaded into the RISC complex containing Argonaute proteins to degrade complementary mRNA, silencing gene expression. RNAi plays roles in gene regulation, genome stability, and provides therapeutic tools for disease
RNA interference (RNAi) is a process triggered by double-stranded RNA that silences gene expression. It was first discovered in plants but has since been found in many eukaryotes. RNAi plays an important role in defending against viruses and mobile genetic elements. It involves an enzyme called Dicer that cleaves long double-stranded RNA into short interfering RNAs (siRNAs). These siRNAs are incorporated into an RNA-induced silencing complex (RISC) that guides mRNA degradation. RNAi can be induced experimentally using synthesized siRNAs or expressed short hairpin RNAs to study gene function or develop applications like crop improvement.
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. Andrew Fire and Craig C. Mello shared the 2006 Nobel Prize in Physiology or Medicine for their work on RNA interference in the nematode worm Caenorhabditis elegans, which they published in 1998. Since the discovery of RNAi and its regulatory potentials, it has become evident that RNAi has immense potential in suppression of desired genes. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression. Two types of small ribonucleic acid (RNA) molecules – microRNA (miRNA) and small interfering RNA (siRNA) – are central to RNA interference. RNAs are the direct products of genes, and these small RNAs can bind to other specific messenger RNA (mRNA) molecules and either increase or decrease their activity, for example by preventing an mRNA from producing a protein. RNA interference has an important role in defending cells against parasitic nucleotide sequences – viruses and transposons. It also influences development.
RNA interference is a cellular mechanism that uses small interfering RNAs (siRNAs) to degrade unwanted RNAs in the cytoplasm. The mechanism involves introducing double-stranded RNA that is processed by an enzyme into siRNAs. These siRNAs then guide another protein complex to cleave homologous messenger RNA, preventing its translation and silencing gene expression in a potent and specific manner.
Sanger sequencing is a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through base pairing with messenger RNA (mRNA) molecules. They are encoded in the genome and are abundant in many human cell types.
- miRNAs play a vital role in genetic regulation and are involved in most biological processes. Aberrant miRNA expression has been implicated in many diseases.
- miRNAs are initially transcribed as long primary transcripts that are processed in the nucleus by the Drosha enzyme into hairpin-shaped precursor miRNAs. These are then exported into the cytoplasm and further processed by the Dicer enzyme into mature miRNAs that can regulate gene expression through pairing with mRNAs.
Transgene silencing refers to the downregulation or suppression of transgene expression in genetically modified organisms. There are several mechanisms by which this can occur, including RNA interference pathways, epigenetic effects, and position effects from chromosomal integration site. Post-transcriptional gene silencing (PTGS) and transcriptional gene silencing (TGS) are two major types. PTGS affects mRNA levels after transcription, while TGS involves DNA/chromatin methylation and inhibits transcription. Virus-induced gene silencing (VIGS) uses recombinant viruses to trigger RNAi against plant genes, and is useful for functional analysis.
This document provides an overview of the origins and mechanisms of microRNAs (miRNAs) and small interfering RNAs (siRNAs). It discusses how double-stranded RNAs are cut by the enzyme Dicer into short RNA fragments that then base pair with mRNAs to induce degradation or transcriptional silencing. Key players in this RNA interference (RNAi) pathway include Dicer, Argonaute proteins, and the RNA-induced silencing complex (RISC). The document contrasts siRNAs, which originate from long double-stranded RNA, and miRNAs, which are encoded from single-stranded RNA precursors that form hairpin structures. It examines the processing steps and roles of various proteins in mediating the effects of si
This document provides an overview of gene silencing, including its history, mechanisms, types, and applications. Gene silencing aims to reduce or eliminate protein production from a gene. There are two main types - transcriptional gene silencing modifies the gene, while post-transcriptional gene silencing uses double-stranded RNA to suppress gene expression. Key mechanisms include antisense oligonucleotides, ribozymes, and RNA interference. Gene silencing has advantages like being cost-effective and specific, and applications in treating diseases, developing resistant crops, and analyzing unknown genes.
This document provides an overview of RNA interference (RNAi) including its mechanism, applications, and methods for delivering small interfering RNA (siRNA). It discusses how dsRNA is processed by the enzyme Dicer into siRNAs which are incorporated into the RISC complex to degrade complementary mRNA. Viral vectors, liposomes, nanoparticles, and chemical modifications are described as methods used to deliver exogenous siRNAs. The document outlines both the therapeutic potential of RNAi and challenges associated with effective siRNA delivery.
This document provides the sequence of the C. elegans cosmid K06A5, which is 24,323 base pairs long. 3955 base pairs of the flat sequence file are shown. The sequence consists only of DNA base letters (A, C, G, T). No other information is provided in the document.
This document summarizes a seminar presentation on antisense RNA technology. The presentation covered:
1. The introduction defined antisense RNA and its potential for crop improvement to meet rising global food demand.
2. The mechanisms of antisense RNA technology were explained, including how antisense RNA binds to mRNA to inhibit translation and activate RNase H degradation.
3. The history of antisense technology was discussed, including its first observation in nature's HOK/SOK system and early experiments in the 1990s that helped define gene silencing.
Sequencing cannabis sativa and cannabis indica, Courtagen Life Sciences, Inc,...Copenhagenomics
1. Medicinal Genomics Corporation sequenced the genomes of several cannabis cultivars including Chemdawg and LA Confidential.
2. Analysis of the genome sequences revealed high levels of polymorphisms and identified several copies of THCA synthase genes with single nucleotide variants.
3. RNA sequencing of different tissues showed tissue-specific expression of potential cannabinoid synthase genes, including a novel root-expressed synthase with a different N-terminal domain.
4. A family tree analysis grouped the potential synthase genes into families across the different cultivars.
This document provides an overview of RNA silencing in plants. It discusses that RNA silencing refers to gene silencing by non-coding RNAs like microRNAs. The mechanism involves double-stranded RNA being processed by an enzyme into small RNAs that guide silencing. There are multiple pathways of RNA silencing in plants, including the microRNA, trans-acting small interfering RNA, RNA-directed DNA methylation, and exogenic RNA pathways. The document also discusses applications of RNA silencing technologies in plants for resistance to stresses and altering traits, as well as advantages and disadvantages.
This document summarizes gene silencing mechanisms including transcriptional gene silencing (TGS) and post-transcriptional gene silencing (PTGS). TGS involves modifications of histones or DNA that alter accessibility of genes to transcriptional machinery. PTGS results from mRNA of a gene being destroyed or blocked, such as via RNA interference (RNAi). RNAi was discovered in C. elegans and involves long dsRNA being processed by the Dicer enzyme into siRNAs that guide an RISC complex to degrade complementary mRNAs. MicroRNAs also guide RISC complexes but typically block translation rather than degradation.
Integrative transcriptomics to study non-coding RNA functionsMaté Ongenaert
Integrative transcriptomics to study non-coding RNA functions
by dr. ir. Pieter Mestdagh - Center for Medical Genetics, Ghent University
Over the last years, non-coding RNAs (e.g. microRNAs and long non-coding RNAs) have emerged as an important layer of the transcriptome. In order to elucidate their function in disease biology, multiple tools have been developed, ranging from miRNA target prediction algorithms to the more advanced integrative genomics approaches. Through the combination of multiple layers of information, integrative genomics allows a more accurate and comprehensive assessment of non-coding RNA functions in human disease. In this presentation, I will discuss different approaches on how to combine multi-level transcriptome data in order to functionally characterize non-coding RNA networks.
The document describes the process of DNA replication. It shows DNA strands unwinding in the nucleus with the help of DNA helicase. The DNA polymerase enzyme then reads each strand and creates complementary DNA strands, using nucleotides that pair with each original strand's sequence. This allows each cell to produce two identical copies of DNA when it divides.
1) The document depicts the process of transcription and translation.
2) It shows DNA being transcribed into mRNA in the nucleus, then the mRNA exiting into the cytoplasm.
3) The mRNA binds to a ribosome in the cytoplasm, where tRNAs bring amino acids to form a protein based on the mRNA sequence.
Transcription takes place in the nucleus and involves splitting DNA into two strands. One strand is used as a template to create a complementary mRNA strand. The mRNA strand exits the nucleus through nuclear pores. Translation takes place in the cytoplasm where ribosomes use the mRNA to assemble amino acids brought by tRNAs into a protein chain based on the mRNA codons. tRNAs match their anticodons to mRNA codons and add amino acids to form the protein.
RNA interference (RNAi) is a mechanism that inhibits gene expression through degradation of mRNA. It was discovered in 1998 when researchers found that injecting double-stranded RNA into worms caused specific gene silencing. The mechanism involves dicer enzymes cutting double-stranded RNA into small interfering RNAs (siRNAs) which are incorporated into the RNA-induced silencing complex (RISC) and guide it to degrade complementary mRNA targets. siRNAs can be designed to target specific genes and various delivery methods exist to introduce siRNAs into cells and organisms. RNAi has applications in research, therapeutics, and agriculture by allowing targeted gene silencing.
Gene silencing and its application in crop improvementVINOD BARPA
Gene silencing is describing as epigenetic processes of gene regulation. Gene silencing is a technique used to turn down or switch off the activity of genes by a mechanism other than genetic modification. That is, a gene which would be expressed (turned on) under normal circumstances is switched off by machinery in the cell.
Gene silencing (GS) is defined as a molecular process involved in the down regulation of specific genes, the mechanisms of Gene silencing that suppress gene activity in plants has extended that control of gene expression. Currently, there are several routes of GS identified in plants, such as: transcriptional gene silencing and post transcriptional (PTGS or RNAi) gene silencing (Fire et al. 1998), microRNA silencing and virus induced gene silencing. All these pathways play an important role at the cellular level, affecting gene regulation and protection against viruses and transposons. The post-transcriptional gene silencing involves breakdown of the mRNA itself by various techniques like Ribozymes, antisense RNA, DNAzymes and RNA interference (RNAi). Among all these techniques RNA interference has emerged as most potent tool to effect targeted gene silencing and is being used to determine the function of genes which are expressed in a constitutive or cell-fate dependent manner.
RNAi interuption mechanism and applicationSumeena Karki
RNA interference is a natural mechanism that inhibits gene expression. It was first discovered accidentally in 1990 when researchers trying to increase pigmentation in petunias found that introduced homologous RNA led to less pigmentation. Further work found similar mechanisms in plants and fungi termed cosuppression and quelling. Craig Mello and Andrew Fire's 1998 paper demonstrating gene silencing in C. elegans using double stranded RNA led to the coining of the term RNAi. The mechanism involves Dicer and Drosha enzymes processing trigger RNA into siRNAs which are loaded into the RISC complex containing Argonaute proteins to degrade complementary mRNA, silencing gene expression. RNAi plays roles in gene regulation, genome stability, and provides therapeutic tools for disease
RNA interference (RNAi) is a process triggered by double-stranded RNA that silences gene expression. It was first discovered in plants but has since been found in many eukaryotes. RNAi plays an important role in defending against viruses and mobile genetic elements. It involves an enzyme called Dicer that cleaves long double-stranded RNA into short interfering RNAs (siRNAs). These siRNAs are incorporated into an RNA-induced silencing complex (RISC) that guides mRNA degradation. RNAi can be induced experimentally using synthesized siRNAs or expressed short hairpin RNAs to study gene function or develop applications like crop improvement.
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. Andrew Fire and Craig C. Mello shared the 2006 Nobel Prize in Physiology or Medicine for their work on RNA interference in the nematode worm Caenorhabditis elegans, which they published in 1998. Since the discovery of RNAi and its regulatory potentials, it has become evident that RNAi has immense potential in suppression of desired genes. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression. Two types of small ribonucleic acid (RNA) molecules – microRNA (miRNA) and small interfering RNA (siRNA) – are central to RNA interference. RNAs are the direct products of genes, and these small RNAs can bind to other specific messenger RNA (mRNA) molecules and either increase or decrease their activity, for example by preventing an mRNA from producing a protein. RNA interference has an important role in defending cells against parasitic nucleotide sequences – viruses and transposons. It also influences development.
RNA interference is a cellular mechanism that uses small interfering RNAs (siRNAs) to degrade unwanted RNAs in the cytoplasm. The mechanism involves introducing double-stranded RNA that is processed by an enzyme into siRNAs. These siRNAs then guide another protein complex to cleave homologous messenger RNA, preventing its translation and silencing gene expression in a potent and specific manner.
Sanger sequencing is a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through base pairing with messenger RNA (mRNA) molecules. They are encoded in the genome and are abundant in many human cell types.
- miRNAs play a vital role in genetic regulation and are involved in most biological processes. Aberrant miRNA expression has been implicated in many diseases.
- miRNAs are initially transcribed as long primary transcripts that are processed in the nucleus by the Drosha enzyme into hairpin-shaped precursor miRNAs. These are then exported into the cytoplasm and further processed by the Dicer enzyme into mature miRNAs that can regulate gene expression through pairing with mRNAs.
Transgene silencing refers to the downregulation or suppression of transgene expression in genetically modified organisms. There are several mechanisms by which this can occur, including RNA interference pathways, epigenetic effects, and position effects from chromosomal integration site. Post-transcriptional gene silencing (PTGS) and transcriptional gene silencing (TGS) are two major types. PTGS affects mRNA levels after transcription, while TGS involves DNA/chromatin methylation and inhibits transcription. Virus-induced gene silencing (VIGS) uses recombinant viruses to trigger RNAi against plant genes, and is useful for functional analysis.
This document provides an overview of the origins and mechanisms of microRNAs (miRNAs) and small interfering RNAs (siRNAs). It discusses how double-stranded RNAs are cut by the enzyme Dicer into short RNA fragments that then base pair with mRNAs to induce degradation or transcriptional silencing. Key players in this RNA interference (RNAi) pathway include Dicer, Argonaute proteins, and the RNA-induced silencing complex (RISC). The document contrasts siRNAs, which originate from long double-stranded RNA, and miRNAs, which are encoded from single-stranded RNA precursors that form hairpin structures. It examines the processing steps and roles of various proteins in mediating the effects of si
This document provides an overview of gene silencing, including its history, mechanisms, types, and applications. Gene silencing aims to reduce or eliminate protein production from a gene. There are two main types - transcriptional gene silencing modifies the gene, while post-transcriptional gene silencing uses double-stranded RNA to suppress gene expression. Key mechanisms include antisense oligonucleotides, ribozymes, and RNA interference. Gene silencing has advantages like being cost-effective and specific, and applications in treating diseases, developing resistant crops, and analyzing unknown genes.
This document provides an overview of RNA interference (RNAi) including its mechanism, applications, and methods for delivering small interfering RNA (siRNA). It discusses how dsRNA is processed by the enzyme Dicer into siRNAs which are incorporated into the RISC complex to degrade complementary mRNA. Viral vectors, liposomes, nanoparticles, and chemical modifications are described as methods used to deliver exogenous siRNAs. The document outlines both the therapeutic potential of RNAi and challenges associated with effective siRNA delivery.
This document provides the sequence of the C. elegans cosmid K06A5, which is 24,323 base pairs long. 3955 base pairs of the flat sequence file are shown. The sequence consists only of DNA base letters (A, C, G, T). No other information is provided in the document.
This document summarizes a seminar presentation on antisense RNA technology. The presentation covered:
1. The introduction defined antisense RNA and its potential for crop improvement to meet rising global food demand.
2. The mechanisms of antisense RNA technology were explained, including how antisense RNA binds to mRNA to inhibit translation and activate RNase H degradation.
3. The history of antisense technology was discussed, including its first observation in nature's HOK/SOK system and early experiments in the 1990s that helped define gene silencing.
Sequencing cannabis sativa and cannabis indica, Courtagen Life Sciences, Inc,...Copenhagenomics
1. Medicinal Genomics Corporation sequenced the genomes of several cannabis cultivars including Chemdawg and LA Confidential.
2. Analysis of the genome sequences revealed high levels of polymorphisms and identified several copies of THCA synthase genes with single nucleotide variants.
3. RNA sequencing of different tissues showed tissue-specific expression of potential cannabinoid synthase genes, including a novel root-expressed synthase with a different N-terminal domain.
4. A family tree analysis grouped the potential synthase genes into families across the different cultivars.
This document provides an overview of RNA silencing in plants. It discusses that RNA silencing refers to gene silencing by non-coding RNAs like microRNAs. The mechanism involves double-stranded RNA being processed by an enzyme into small RNAs that guide silencing. There are multiple pathways of RNA silencing in plants, including the microRNA, trans-acting small interfering RNA, RNA-directed DNA methylation, and exogenic RNA pathways. The document also discusses applications of RNA silencing technologies in plants for resistance to stresses and altering traits, as well as advantages and disadvantages.
This document summarizes gene silencing mechanisms including transcriptional gene silencing (TGS) and post-transcriptional gene silencing (PTGS). TGS involves modifications of histones or DNA that alter accessibility of genes to transcriptional machinery. PTGS results from mRNA of a gene being destroyed or blocked, such as via RNA interference (RNAi). RNAi was discovered in C. elegans and involves long dsRNA being processed by the Dicer enzyme into siRNAs that guide an RISC complex to degrade complementary mRNAs. MicroRNAs also guide RISC complexes but typically block translation rather than degradation.
Integrative transcriptomics to study non-coding RNA functionsMaté Ongenaert
Integrative transcriptomics to study non-coding RNA functions
by dr. ir. Pieter Mestdagh - Center for Medical Genetics, Ghent University
Over the last years, non-coding RNAs (e.g. microRNAs and long non-coding RNAs) have emerged as an important layer of the transcriptome. In order to elucidate their function in disease biology, multiple tools have been developed, ranging from miRNA target prediction algorithms to the more advanced integrative genomics approaches. Through the combination of multiple layers of information, integrative genomics allows a more accurate and comprehensive assessment of non-coding RNA functions in human disease. In this presentation, I will discuss different approaches on how to combine multi-level transcriptome data in order to functionally characterize non-coding RNA networks.
The document describes the process of DNA replication. It shows DNA strands unwinding in the nucleus with the help of DNA helicase. The DNA polymerase enzyme then reads each strand and creates complementary DNA strands, using nucleotides that pair with each original strand's sequence. This allows each cell to produce two identical copies of DNA when it divides.
1) The document depicts the process of transcription and translation.
2) It shows DNA being transcribed into mRNA in the nucleus, then the mRNA exiting into the cytoplasm.
3) The mRNA binds to a ribosome in the cytoplasm, where tRNAs bring amino acids to form a protein based on the mRNA sequence.
Transcription takes place in the nucleus and involves splitting DNA into two strands. One strand is used as a template to create a complementary mRNA strand. The mRNA strand exits the nucleus through nuclear pores. Translation takes place in the cytoplasm where ribosomes use the mRNA to assemble amino acids brought by tRNAs into a protein chain based on the mRNA codons. tRNAs match their anticodons to mRNA codons and add amino acids to form the protein.
Transcription takes place in the nucleus and involves splitting DNA into two strands. One strand is used as a template to create a complementary mRNA strand. The mRNA strand exits the nucleus through nuclear pores. Translation takes place in the cytoplasm where ribosomes use the mRNA to assemble amino acids brought by tRNAs into a protein chain based on the mRNA codons. tRNAs match their anticodons to mRNA codons and add amino acids to form the protein.
This document discusses the process of DNA transcription and translation. It explains the basic structure of DNA and RNA, including their nitrogenous bases. It then outlines the six steps of transcription, where DNA is unzipped and an mRNA copy is produced. Finally, it describes the process of translation, where mRNA directs the assembly of amino acids into proteins by binding to transfer RNA and ribosomes. The overall process converts genetic information stored in DNA into functional proteins.
This document discusses the process of DNA transcription and translation. It explains the basic structure of DNA and RNA, including their nitrogenous bases. It then outlines the six step process of transcription, where DNA is unzipped and an mRNA copy is produced. Finally, it summarizes the process of translation, where the mRNA copy is used by ribosomes to produce a protein through the joining of amino acids specified by the mRNA codons.
The document summarizes the processes of transcription and translation. In transcription, RNA polymerase attaches to the promoter region of DNA and unwinds the double helix to access the coding region and produce a messenger RNA (mRNA) copy. Translation then involves mRNA interacting with ribosomes and transfer RNA to produce a chain of amino acids that folds into a functional protein structure based on its 3D shape.
The document describes the process of transcription and translation in prokaryotic cells. During transcription, RNA polymerase unwinds DNA and synthesizes mRNA using complementary base pairing. The mRNA then exits the nucleus. During translation, the mRNA binds to ribosomes where tRNA matches codons and amino acids are linked together via peptide bonds to form a protein.
The document summarizes the process of transcription and translation in protein synthesis. [1] Transcription occurs in the cell nucleus, where RNA polymerase uses DNA as a template to produce mRNA. [2] The mRNA exits the nucleus and moves to the cytoplasm, where it binds to ribosomes. [3] Translation then occurs, as the ribosome reads the mRNA and pairs tRNAs with their complementary anticodons to add amino acids in the specified order and produce a polypeptide chain.
The document summarizes the process of transcription and translation in protein synthesis. [1] Transcription occurs in the cell nucleus, where RNA polymerase uses DNA as a template to produce mRNA. [2] The mRNA exits the nucleus and moves to the cytoplasm, where it binds to ribosomes. [3] Translation then occurs, as the ribosome reads the mRNA and pairs tRNAs with their complementary anticodons to add amino acids in the specified order and produce a polypeptide chain.
chapter 9 - dna powerpoint for forensicskaganmiller24
This document provides an overview of DNA and its use in forensics. It discusses how DNA can be used to link suspects to crime scenes, identify missing or dead persons, and link suspects to events. It describes the structure of DNA, including the double helix structure and base pairing. It explains how DNA is replicated and how genes instruct the production of proteins. The document outlines early DNA fingerprinting techniques like RFLPs and VNTRs, and more modern techniques using STR analysis and PCR. It discusses the use of DNA fingerprinting in paternity testing, criminal cases, and Y-STR analysis.
RNA polymerase unwinds DNA and copies its bases to form mRNA. The mRNA breaks away from DNA and moves to ribosomes in the cytoplasm. At the ribosomes, the mRNA is read and its codons are translated to amino acids which are joined together to form a protein.
The document summarizes the process of protein synthesis in cells. It occurs in two main steps - transcription and translation. In transcription, RNA polymerase in the nucleus copies DNA into mRNA. In translation, ribosomes in the cytoplasm read the mRNA and assemble amino acids into a protein chain using transfer RNA molecules. The end result is a functional protein that forms from the folding and shaping of the amino acid chain.
This document provides an overview of molecular pathology and various molecular techniques. It discusses the use of nucleic acid testing for clinical purposes such as diagnosis, prognosis, and pharmacogenetics/pharmacogenomics. It describes several molecular techniques including DNA sequencing, PCR, real-time PCR, FISH, microarrays, and their applications. It also discusses DNA/RNA structure, gene expression, mutations, molecular pathology specimen handling, and instrumentation.
This document discusses nucleotide chemistry and nucleic acid chemistry. It covers the structures of nucleotides, nucleosides, and nucleic acids including DNA and RNA. Some key points include:
- Nucleotides are composed of a pentose sugar, phosphate group, and a nitrogenous base. DNA and RNA are polymers of nucleotides.
- DNA exists as a double helix with complementary base pairing between strands. It can undergo denaturation and renaturation.
- RNA includes tRNA, mRNA, rRNA and other non-coding RNA. tRNA forms a cloverleaf structure and carries amino acids. mRNA encodes proteins.
- Prokaryotes like bacteria have circular chromosomes without nuclei, while eukaryotes package
DNA contains the genetic material of organisms and is made up of nucleotides with a sugar-phosphate backbone. DNA is organized into chromosomes within the nucleus of eukaryotic cells. Genetic information flows from DNA to protein through two main processes - transcription of DNA to mRNA and translation of mRNA to protein using transfer RNA and ribosomes.
The document describes the process of transcription and translation in a cell. During transcription, RNA polymerase copies DNA in the nucleus to produce mRNA. The mRNA then exits the nucleus through nuclear pores. During translation, the mRNA binds to ribosomes in the cytoplasm. tRNAs bring amino acids to the ribosome based on codon-anticodon binding. The amino acids are linked together to form a polypeptide chain, which later folds into a functional protein.
Transcription and Translation Made By Meredith Gallinapunxsyscience
The document depicts the process of DNA replication. It shows DNA strands unwinding and separating. The bases on each strand - thymine, adenine, guanine and cytosine - pair up to form new DNA strands. Enzymes such as DNA polymerase and helicase are involved in copying the genetic material and unwinding the DNA helix. The process results in two identical DNA molecules from the original DNA.
The document depicts the process of DNA replication. It shows DNA strands unwinding and separating. DNA polymerase then adds complementary nucleotides to each strand to create two new double helix DNA molecules. Key steps shown include unwinding of the DNA double helix by helicase, addition of nucleotides by DNA polymerase, and separation of the DNA strands.
Similar to Mc.transcription translationflipbook (20)
Gregor Mendel was an Austrian monk who is considered the father of genetics. He conducted experiments with pea plants in which he studied 7 different traits. Through his experiments, Mendel discovered the principles of heredity, including that traits are passed from parents to offspring through discrete units called genes, and that some genes are dominant while others are recessive. When Mendel crossed plants with different traits, he found that the offspring expressed the traits of only one parent, not a blend, and that recessive traits could reappear in later generations. This led Mendel to propose that genes segregate and assort independently during the formation of gametes.
The document describes the process of protein synthesis. It explains that RNA polymerase first breaks the hydrogen bonds of DNA to copy it and make an mRNA strand. The mRNA strand then leaves the nucleus through the nuclear pore into the cytoplasm. In the cytoplasm, the mRNA binds to a ribosome where tRNA reads its bases and adds complementary amino acids to form a polypeptide chain.
Transcription occurs in the cell nucleus where DNA is unzipped and RNA polymerase adds complementary RNA nucleotides to the DNA template strand, forming mRNA. The mRNA is processed - a cap and tail are added and introns are removed. The completed mRNA contains codons of three nucleotides that code for amino acids. Translation occurs in the cytoplasm where the mRNA binds to ribosomes and tRNA molecules with matching anticodons deliver amino acids specified by mRNA codons, assembling the polypeptide chain specified by the mRNA.
This flip book depicts the process of protein synthesis, showing how DNA is transcribed into mRNA, which is then translated by ribosomes into a polypeptide chain. The flip book steps through transcription, where RNA polymerase copies DNA into mRNA, then translation, where the mRNA passes through the ribosome and interacts with tRNA and rRNA to add amino acids in the correct order specified by codons until a full protein is synthesized.
This document is a flip book that summarizes the process of protein synthesis. It shows how DNA is transcribed into mRNA by RNA polymerase in the nucleus. The mRNA is then transported out of the nucleus through the nuclear pore and binds to the ribosome in the cytoplasm. The ribosome reads the mRNA codons and binds transfer RNA (tRNA) with complementary anticodons. The tRNA brings amino acids to form peptide bonds and a polypeptide chain, which eventually folds into a functional protein.
This flip book depicts the process of protein synthesis, showing how DNA is transcribed into mRNA, which is then translated by ribosomes into a polypeptide chain. The flip book steps through transcription, where RNA polymerase copies DNA into mRNA, then translation, where the mRNA passes through the ribosome and interacts with tRNA and rRNA to add amino acids in the correct order specified by codons until a full protein is synthesized.
The document describes the process of transcription and translation in a cell. RNA polymerase unwinds DNA and creates an mRNA strand in the nucleus. The mRNA strand then moves to the cytoplasm through the nuclear pore. In the cytoplasm, the mRNA strand binds to a ribosome where tRNA brings amino acids to add to a growing polypeptide chain based on the mRNA codons. The polypeptide chain then folds into the final 3D protein structure.
The document describes the process of protein synthesis, which occurs in two steps: transcription and translation. In transcription, DNA is unwound and an mRNA strand is created using nucleotides. In translation, the mRNA strand is sent to the cytoplasm where it binds to a ribosome. tRNA molecules then bind to the ribosome and add amino acids specified by the mRNA code, forming a peptide bond between amino acids and creating a protein chain.
The document describes the process of protein synthesis, which occurs in two steps: transcription and translation. In transcription, DNA is unwound and an mRNA strand is created using nucleotides. The mRNA strand is then released and the DNA strands rebind. In translation, the mRNA moves to the cytoplasm and binds to ribosomes. tRNA molecules bind to the ribosome according to the mRNA code, and each tRNA connects to a specific amino acid. Translation begins as tRNA molecules form base pairs with the mRNA, and peptide bonds form between the amino acids, creating a protein.
The document describes the process of protein synthesis, which occurs in two main steps - transcription and translation. Transcription takes place in the nucleus and involves RNA polymerase copying genetic information from DNA to mRNA. Translation occurs in the cytoplasm at ribosomes, where the mRNA code is used to assemble amino acids in the correct order to produce a protein. The start codon on mRNA pairs with a complementary tRNA to initiate translation.
DNA replication begins at the origin of replication where DNA helicase unwinds and unzips the double helix. DNA polymerase reads the bases on one strand and adds complementary bases to the other strand. The leading strand is replicated continuously while the lagging strand is replicated discontinuously in fragments called Okazaki fragments. DNA primase adds primers to fill in the lagging strand, and DNA ligase seals the fragments together with phosphodiester bonds.
This protein synthesis flip book illustrates the process of transcription and translation. It shows DNA being transcribed into mRNA by RNA polymerase in the nucleus. The mRNA is then transported to the cytoplasm where it passes through ribosomes. During this process, transfer RNA (tRNA) molecules match to the mRNA codons and add amino acids to form a polypeptide chain through peptide bonds. Eventually a full protein is synthesized from the mRNA instructions.
The document outlines the process of protein synthesis which has two main parts - transcription and translation. In transcription, mRNA strands are created in the nucleus from a DNA template with the help of RNA polymerase. The mRNA then exits the nucleus through nuclear pores. In translation, which occurs in the cytoplasm, ribosomes read the mRNA to produce a protein. Transfer RNA molecules match their anticodons to mRNA codons and bring corresponding amino acids. The amino acids are linked together by peptide bonds to form a polypeptide chain, which becomes a protein when translation is complete.
Protein synthesis flipbook @yoloswagginator24punxsyscience
The document summarizes the process of protein synthesis. It describes how RNA polymerase unwinds DNA and copies it to mRNA. The mRNA strand then exits the nucleus through the nuclear pore and moves to ribosomes. At the ribosomes, the mRNA is read and translated to form a polypeptide chain of amino acids.
The document outlines the process of protein synthesis which has two main parts - transcription and translation. In transcription, mRNA strands are created in the nucleus from a DNA template with the help of RNA polymerase. The mRNA then exits the nucleus through nuclear pores. In translation, which occurs in the cytoplasm, ribosomes read the mRNA to produce a protein. Transfer RNA molecules match their anticodons to mRNA codons and bring corresponding amino acids. The amino acids are linked together by peptide bonds to form a polypeptide chain, which becomes a protein when translation is complete.
The document shows the process of protein synthesis:
1) In the nucleus, RNA polymerase unzips DNA and copies its sequence into a messenger RNA (mRNA) strand.
2) The mRNA exits the nucleus through the nuclear pore and enters the cytoplasm.
3) In the cytoplasm, the mRNA binds to a ribosome which reads its sequence in groups of three bases (codons).
4) Transfer RNA (tRNA) molecules matching these codons bring specific amino acids to the ribosome.
5) The amino acids are linked together to form a polypeptide chain, which later folds into a functional protein.
The document is a flip book that summarizes the key steps of protein synthesis: 1) DNA is unwound in the cell nucleus and an mRNA strand is produced, 2) the mRNA strand moves from the nucleus to the cytoplasm where ribosomes are located, 3) ribosomes read the mRNA strand and amino acids are attached through peptide bonds to form a protein, which then folds into its tertiary structure.
The document summarizes the process of protein synthesis. DNA in the nucleus is transcribed into mRNA by RNA polymerase. The mRNA then exits the nucleus and binds to a ribosome in the cytoplasm. The ribosome reads the mRNA and uses transfer RNA molecules to add amino acids to form a protein chain. The protein folds into its final shape.
The document discusses protein synthesis in cells. It explains that RNA polymerase in the cell nucleus reads DNA and synthesizes mRNA. The mRNA then exits the nucleus through nuclear pores and binds to ribosomes. At the ribosomes, tRNA matches codons on the mRNA and releases amino acids, forming peptide bonds between amino acids to create a polypeptide chain. When the ribosome reaches a stop codon, the polypeptide releases and folds into its tertiary structure to become a functional protein.
The process of transcription begins in the cell nucleus, where RNA polymerase breaks apart DNA and uses it as a template to create mRNA strands. During this process, thymine is replaced with uracil to form RNA. The mRNA strand then exits the nucleus through a nuclear pore. Translation occurs in the cytoplasm, where the mRNA is read by ribosomes in groups of three codons. Transfer RNA molecules bring amino acids to the ribosome based on codon-anticodon base pairing. As the ribosome moves along the mRNA, the growing polypeptide chain is released once a stop codon is reached.
2. Transcription happens in the Nucleus. Once RNA
Polymerase goes through one strand of DNA, the mRNA
travels through the nuclear pore into the cytoplasm.
57. DNA Transcription is the process of copying the DNA sequence of a gene and
transporting it to the cytoplasm of the cell. In the beginning, the transcription process
is occurring in the nucleus, as said at the beginning of the power point. After RNA
Polymerase attaches complementary nucleotides to the template, Thymine is replaced
by Uracil. So when RNA nucleotides are bound to DNA nucleotides; Adenine binds with
Uracil and Guanine binds with Cytosine.
212. During translation, mRNA enters the cytoplasm. Then, a ribosome reads
the mRNA strand to tell tRNA what amino acid to bring. Next, the tRNA
matches its codons with that of the mRNA and leaves the amino acid
there to be connected to another amino acid by a peptide bond. After
the ribosome reaches the end codon, it stops reading the mRNA and the
protein is completed.